Back to top Open menu arrow
Purchase PDF Reprints
Sections
No sections available
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

Original Research Focus on Suicide November 23, 2022

Bad Dreams and Nightmares Preceding Suicidal Behaviors

; ; ; ; ; ; ;

J Clin Psychiatry 2023;84(1):22m14448

ABSTRACT

Objective: Nightmares seem to predict suicidal behaviors, and the aim of this study is to explore the chronology and trajectories of alterations in dream contents before a suicidal crisis, distinguishing 3 different experiences: bad dreams, nightmares, and suicidal scenarios during dreams.

Methods: This naturalistic study included individuals hospitalized between January 2021 and May 2021 in a psychiatric post–emergency room unit for suicidal crisis (thoughts and attempts).

Results: The study observed that 80% (n = 32/40) of patients had altered dreams (AD) before the suicidal crisis, including 27 (67.5%) with bad dreams, 21 (52.5%) with nightmares (bad dreams that awaken the sleeper), and 9 (22.5%) with suicidal scenarios during dreams. No differences were observed between the AD group versus patients with no altered dreams (ND) regarding sociodemographic characteristics. We observed a progression of dream content alterations: bad dreams appear 111 days (4 months) before the suicidal crisis, then nightmares appear 87.3 days before (3 months), and suicidal scenarios during dreams were reported 45.2 days before (1.5 months). For the AD and ND populations in suicidal crisis, 80% had at least 1 subtype of dream alterations, 40% had bad dreams and nightmares, and 17.5% had all 3 subtypes. The AD group, compared to the ND group, had significantly more family history of insomnia (P = .046). Almost all patients (97.5%) had depressive symptoms (Montgomery-Asberg Depression Rating Scale [MADRS] score ≥ 7; 82.5% had moderate to severe symptoms, MADRS ≥ 20), 60% had insomnia (Insomnia Severity Index > 14), 92.5% had altered sleep quality (Pittsburgh Sleep Quality Index > 5), and 57.5% reported sleepiness (Epworth Sleepiness Scale > 10).

Conclusions: Dream alterations and their progression can be readily assessed and may help to better identify prodromal signs of suicidal behaviors.

ABSTRACT

Objective: Nightmares seem to predict suicidal behaviors, and the aim of this study is to explore the chronology and trajectories of alterations in dream contents before a suicidal crisis, distinguishing 3 different experiences: bad dreams, nightmares, and suicidal scenarios during dreams.

Methods: This naturalistic study included individuals hospitalized between January 2021 and May 2021 in a psychiatric post–emergency room unit for suicidal crisis (thoughts and attempts).

Results: The study observed that 80% (n = 32/40) of patients had altered dreams (AD) before the suicidal crisis, including 27 (67.5%) with bad dreams, 21 (52.5%) with nightmares (bad dreams that awaken the sleeper), and 9 (22.5%) with suicidal scenarios during dreams. No differences were observed between the AD group versus patients with no altered dreams (ND) regarding sociodemographic characteristics. We observed a progression of dream content alterations: bad dreams appear 111 days (4 months) before the suicidal crisis, then nightmares appear 87.3 days before (3 months), and suicidal scenarios during dreams were reported 45.2 days before (1.5 months). For the AD and ND populations in suicidal crisis, 80% had at least 1 subtype of dream alterations, 40% had bad dreams and nightmares, and 17.5% had all 3 subtypes. The AD group, compared to the ND group, had significantly more family history of insomnia (P = .046). Almost all patients (97.5%) had depressive symptoms (Montgomery-Asberg Depression Rating Scale [MADRS] score ≥ 7; 82.5% had moderate to severe symptoms, MADRS ≥ 20), 60% had insomnia (Insomnia Severity Index > 14), 92.5% had altered sleep quality (Pittsburgh Sleep Quality Index > 5), and 57.5% reported sleepiness (Epworth Sleepiness Scale > 10).

Conclusions: Dream alterations and their progression can be readily assessed and may help to better identify prodromal signs of suicidal behaviors.

This content is restricted to subscribers

  1. World Health Organization. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. World Health Organization; 2018.
  2. Fazel S, Runeson B. Suicide. N Engl J Med. 2020;382(3):266–274. PubMed CrossRef
  3. Goldstein TR, Bridge JA, Brent DA. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol. 2008;76(1):84–91. PubMed CrossRef
  4. Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am J Psychiatry. 2002;159(6):909–916. PubMed CrossRef
  5. Belsher BE, Smolenski DJ, Pruitt LD, et al. Prediction models for suicide attempts and deaths: a systematic review and simulation. JAMA Psychiatry. 2019;76(6):642–651. PubMed CrossRef
  6. Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry. 2012;73(9):e1160–e1167. PubMed CrossRef
  7. Bernert RA, Nadorff MR. Sleep disturbances and suicide risk. Sleep Med Clin. 2015;10(1):35–39. PubMed CrossRef
  8. Karia SB, Mehta N, Harshe D, et al. Insomnia, dreams, and suicide: connecting links. Ind Psychiatry J. 2016;25(2):155–159. PubMed CrossRef
  9. Benard V, Geoffroy PA, Bellivier F. Seasons, circadian rhythms, sleep and suicidal behaviors vulnerability [Saisons, rythmes circadiens, sommeil et vulnérabilité aux conduites suicidaires]. Encephale. 2015;41(suppl 1):S29–S37. PubMed CrossRef
  10. Christodoulou C, Efstathiou V, Bouras G, et al. Seasonal variation of suicide: a brief review. Encephalos. 2012;49:73–79.
  11. Palagini L, Miniati M, Caruso D, et al. Predictors of suicidal ideation and preparatory behaviors in individuals with bipolar disorder: the contribution of chronobiological dysrhythmicity and its association with hopelessness. J Clin Psychiatry. 2021;82(2):20m13371. PubMed CrossRef
  12. Ambar Akkaoui M, Lejoyeux M, d’Ortho MP, et al. Nightmares in patients with major depressive disorder, bipolar disorder, and psychotic disorders: a systematic review. J Clin Med. 2020;9(12):3990. PubMed CrossRef
  13. Perlis ML, Grandner MA, Brown GK, et al. Nocturnal wakefulness as a previously unrecognized risk factor for suicide. J Clin Psychiatry. 2016;77(6):e726–e733. PubMed CrossRef
  14. Benard V, Etain B, Vaiva G, et al. Sleep and circadian rhythms as possible trait markers of suicide attempt in bipolar disorders: an actigraphy study. J Affect Disord. 2019;244:1–8. PubMed CrossRef
  15. Geoffroy PA, Oquendo MA, Courtet P, et al. Sleep complaints are associated with increased suicide risk independently of psychiatric disorders: results from a national 3-year prospective study. Mol Psychiatry. 2021;26(6):2126–2136. PubMed CrossRef
  16. Sandman N, Valli K, Kronholm E, et al. Nightmares: prevalence among the Finnish general adult population and war veterans during 1972–2007. Sleep (Basel). 2013;36(7):1041–1050. PubMed CrossRef
  17. Janson C, Gislason T, De Backer W, et al. Prevalence of sleep disturbances among young adults in three European countries. Sleep. 1995;18(7):589–597. PubMed
  18. Li SX, Zhang B, Li AM, et al. Prevalence and correlates of frequent nightmares: a community-based 2-phase study. Sleep. 2010;33(6):774–780. PubMed CrossRef
  19. Blagrove M, Farmer L, Williams E. The relationship of nightmare frequency and nightmare distress to well-being. J Sleep Res. 2004;13(2):129–136. PubMed CrossRef
  20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Fifth Edition. Washington, DC: American Psychiatric Association; 2013.
  21. American Academy of Sleep Medicine. International Classification of Sleep Disorders – 3rd ed (ICSD-3). American Association of Sleep Medicine; 2014. https://learn.aasm.org/Listing/a1341000002XmRvAAK
  22. Simor P, Horváth K, Gombos F, et al. Disturbed dreaming and sleep quality: altered sleep architecture in subjects with frequent nightmares. Eur Arch Psychiatry Clin Neurosci. 2012;262(8):687–696. PubMed CrossRef
  23. Tanskanen A, Tuomilehto J, Viinamäki H, et al. Nightmares as predictors of suicide. Sleep. 2001;24(7):844–847. PubMed CrossRef
  24. Ağargün MY, Cilli AS, Kara H, et al. Repetitive and frightening dreams and suicidal behavior in patients with major depression. Compr Psychiatry. 1998;39(4):198–202. PubMed CrossRef
  25. Speed KJ, Drapeau CW, Nadorff MR. Differentiating single and multiple suicide attempters: what nightmares can tell us that other predictors cannot. J Clin Sleep Med. 2018;14(5):829–834. PubMed CrossRef
  26. Ambar Akkaoui M, D’ortho MP, Gourevitch R, et al. A study of nightmares in patients with psychiatric disorders. Psychiatry Clin Neurosci. 2022;76(3):89–91. CrossRef
  27. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266–1277. PubMed CrossRef
  28. The Columbia Lighthouse Project. Center for Suicide Risk Assessment. The Columbia Suicide Severity Rating Scale (C - SSRS). Supporting Evidence; 2019.
  29. Chahoud M, Chahine R, Salameh P, et al. Reliability, factor analysis and internal consistency calculation of the Insomnia Severity Index (ISI) in French and in English among Lebanese adolescents. eNeurologicalSci. 2017;7:9–14. PubMed CrossRef
  30. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307. PubMed CrossRef
  31. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. PubMed CrossRef
  32. Dietch JR, Taylor DJ, Sethi K, et al. Psychometric evaluation of the PSQI in US college students. J Clin Sleep Med. 2016;12(8):1121–1129. PubMed CrossRef
  33. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540–545. PubMed CrossRef
  34. Taillard J, Philip P, Chastang JF, et al. Validation of Horne and Ostberg Morningness-Eveningness Questionnaire in a middle-aged population of French workers. J Biol Rhythms. 2004;19(1):76–86. PubMed CrossRef
  35. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001;179(6):540–544. PubMed CrossRef
  36. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382–389. PubMed CrossRef
  37. Hinz A, Klein AM, Brähler E, et al. Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. J Affect Disord. 2017;210:338–344. PubMed CrossRef
  38. Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. PubMed CrossRef
  39. The Jamovi Project. Jamovi (Version 1.8) [computer software]. 2021. https://www.jamovi.org
  40. Fox J, Weisberg S. Car: Companion to Applied Regression [R Package]. 2020. https://cran.r-project.org/web/packages/car/index.html
  41. R Core Team. R: A Language and Environment for Statistical Computing (Version 4.0) [computer software]. 2021. R Packages retrieved from MRAN snapshot April 1, 2021. https://cran.r-project.org
  42. Li SX, Lam SP, Chan JWY, et al. Residual sleep disturbances in patients remitted from major depressive disorder: a 4-year naturalistic follow-up study. Sleep (Basel). 2012;35(8):1153–1161. PubMed CrossRef
  43. Agargun MY, Besiroglu L, Cilli AS, et al. Nightmares, suicide attempts, and melancholic features in patients with unipolar major depression. J Affect Disord. 2007;98(3):267–270. PubMed CrossRef
  44. Robert G, Zadra A. Measuring nightmare and bad dream frequency: impact of retrospective and prospective instruments. J Sleep Res. 2008;17(2):132–139. PubMed CrossRef
  45. Sjöström N, Waern M, Hetta J. Nightmares and sleep disturbances in relation to suicidality in suicide attempters. Sleep. 2007;30(1):91–95. PubMed CrossRef
  46. Lamis DA, Innamorati M, Erbuto D, et al. Nightmares and suicide risk in psychiatric patients: the roles of hopelessness and male depressive symptoms. Psychiatry Res. 2018;264:20–25. PubMed CrossRef
  47. Sjöström N, Hetta J, Waern M. Persistent nightmares are associated with repeat suicide attempt: a prospective study. Psychiatry Res. 2009;170(2–3):208–211. PubMed CrossRef
  48. Kahn D. Reactions to dream content: continuity and non-continuity. Front Psychol. 2019;10:2676. PubMed CrossRef
  49. Schredl M, Göritz AS. Nightmare themes: an online study of most recent nightmares and childhood nightmares. J Clin Sleep Med. 2018;14(3):465–471. PubMed CrossRef
  50. Gieselmann A, Ait Aoudia M, Carr M, et al. Aetiology and treatment of nightmare disorder: state of the art and future perspectives. J Sleep Res. 2019;28(4):e12820. PubMed CrossRef
  51. Agargun MY, Kara H, Özer ÖA, et al. Clinical importance of nightmare disorder in patients with dissociative disorders. Psychiatry Clin Neurosci. 2003;57(6):575–579. PubMed CrossRef
  52. Thünker J, Pietrowsky R. Effectiveness of a manualized imagery rehearsal therapy for patients suffering from nightmare disorders with and without a comorbidity of depression or PTSD. Behav Res Ther. 2012;50(9):558–564. PubMed CrossRef
  53. Geoffroy PA, Scott J. Prodrome or risk syndrome: what’s in a name? Int J Bipolar Disord. 2017;5(1):7. PubMed CrossRef
  54. World Health Organization, others. Global Health Estimates 2013: Deaths by Cause, Age and Sex, Estimates for 2000–2012. World Health Organization. Published online 2014.
  55. World Health Organization. Suicide Data. WHO website. https://www.who.int/mental_health/prevention/suicide/suicideprevent/en/. Accessed January 16, 2017.
  56. Waltman SH, Shearer D, Moore BA. Management of post-traumatic nightmares: a review of pharmacologic and nonpharmacologic treatments since 2013. Curr Psychiatry Rep. 2018;20(12):108. PubMed CrossRef
  57. Pompili M, Venturini P, Palermo M, et al. Mood disorders medications: predictors of nonadherence: review of the current literature. Expert Rev Neurother. 2013;13(7):809–825. PubMed CrossRef
Buy PDF for $40

Please sign in or purchase this PDF for $40.

Save Save

Share Share

Cite Cite

Vol 86 • 2025 • Number 1

Read the Current Issue

Brief Report

Sex Differences in PTSD among US Military Veterans

Commentary

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Clinical and Practical Psychopharmacology

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Commentary

Evolving Care and Research Priorities in ADHD

Original Research

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Systematic Review

Efficacy and Safety of Memantine for Children and Adults with ADHD
View current Issue

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe